TOG Review (RCOG Journal)

MRCOG Part 2

Maternal Medicine

Lichen sclerosus for the obstetrician

Key Statistics

  • ≤3% — Population prevalence of vulval LS
  • 5%→<1% — Lifetime vulval cancer risk, untreated vs TCS-treated
  • 60% — Reported symptom worsening post-partum (survey, n=206 pregnancies)

Don't-miss facts

  1. TCS is safe throughout pregnancy and post-partum/lactation – no association with congenital abnormality, preterm birth, low Apgar, or fetal death

  2. Avoid calcineurin inhibitors and oral retinoids in pregnancy; stop topical retinoids 1 month before conception

  3. Mode of birth per standard obstetric indications – LS alone rarely mandates Caesarean; vaginal birth usually fine if well controlled, no significant introital stenosis

  4. Only 12% of women with LS report an affected first-degree relative – no genetic/blood diagnostic test available

  5. Compliance with TCS drops post-partum (69%→76%→60% in one series) → increase surveillance/follow-up post-partum

  6. 60% report symptom worsening post-partum (survey, n=206 pregnancies), worsening progressively over first 12 months

  7. Low-dose vaginal oestradiol (≤10 mcg) not detected in breast milk in available studies – safe adjunct for post-partum atrophic symptoms regardless of lactation status

  8. Lifetime vulval cancer risk with poorly controlled LS ~5%, falls to <1% with adequate TCS treatment/monitoring

Pregnancy TCS options

Continue: clobetasol 0.05% or mometasone 0.1%, once–twice weekly maintenance Avoid: calcineurin inhibitors, oral retinoids

Abbreviation Key

  • LS — lichen sclerosus
  • GSM — genitourinary syndrome of menopause
  • TCS — topical corticosteroid
  • GSL — genitourinary syndrome of lactation
  • HLA — human leukocyte antigen
  • PFPT — pelvic floor physiotherapy
  • miRNA — micro RNA
  • OASI — obstetric anal sphincter injury
  • VVA — vulvovaginal atrophy
  • Euroguiderm — European Dermatology Forum guideline body

Source: Lewis FM, Lev-Sagie A, Krapf J. Lichen sclerosus for the obstetrician: a review of comprehensive care for pregnancy, parturition, post-partum and breastfeeding. The Obstetrician & Gynaecologist 2026;28:93–99. doi:10.1111/tog.70032

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free